IMPORTANT ANNOUNCEMENT – Here For You During COVID-19

Even though we are in uncharted territory everyone at Summers, Rufolo & Rodgers, P.C. wants you to know we are here for you. read more
Summers, Rufolo & Rodgers
Call For A Free Consultation
423-933-2738
View Our Practice Areas

Defective Drugs Archives

OxyContin maker Purdue pleads guilty to 3 criminal charges

The painkiller OxyContin has played an outsized role in the opioid crisis, which has killed at least 470,000 people since 2000. Originally intended as a drug for severe pain, OxyContin was prescribed widely for moderate pain, exposing millions to the risk of addiction and overdose.

Bayer to settle US Essure contraceptive claims for $1.6 billion

Conceptus, Inc.'s product Essure was an implantable contraceptive device used by millions of women in the U.S. and abroad. Germany-based Bayer AG acquired Conceptus in 2013 for $1.1 billion. In 2016, the FDA required a safety warning on Essure's label and Bayer stopped selling it in 2018.

Common heartburn drugs pulled over cancer concerns

Acid reflux and heartburn is a common condition for which many Americans take medication to relieve daily symptoms. But the Food and Drug Administration (FDA) has become concerned that a drug called ranitidine, found in prescription drugs and the over-the-counter heartburn medicine Zantac, could cause cancer.

Did Walmart obstruct the opioid investigations?

After a civil lawsuit is filed, a process goes on called "discovery." In this process, each side gets to investigate and gather information, including from the other side. This includes asking questions to be answered under oath, asking for admissions, seeking copies of documents and generally attempting to discover the other's involvement.

Weight loss drug Belviq pulled from market for cancer risk

Recently, the U.S. Food and Drug Administration asked the Japanese drug maker Eisai Inc. to pull its weight loss drug Belviq from the market due to concerns the drug can slightly increase the user's risk of cancer. The extended release version of the drug is also being pulled. Eisai issued a statement saying it withdrew the drug voluntarily but disagrees with the FDA's interpretation of the data. It said it still believes Belviq has benefits that outweigh the risk.

Addicted to Purdue Pharma opioids? June 30 deadline for claims

People injured by their opioids can file personal injury claims directly against Purdue Pharma, the manufacturer of the painkillers OxyContin, MS Contin and Ryzolt. Purdue is in bankruptcy, and part of that process involves divvying up the company's assets among creditors and claimants.

California may declare acetaminophen a known human carcinogen

Acetaminophen is one of the most common over-the-counter drugs in the world. It is known by the brand names Tylenol and Excedrin, and it is found in many OTC remedies for pain, flu and fever. It has been available without a prescription in the U.S. since 1955. Now, the State of California is considering labeling it a known human carcinogen.

Warning: Gabapentin with opioids can cause breathing problems

The U.S. Food and Drug Administration has ordered manufacturers to include warnings on the product labels for gabapentinoids, certain drugs that depress the central nervous system, and opioids. The warning will indicate that taking gabapentinoids with opioids can cause serious breathing problems. These problems were also found in people taking gabapentin who had underlying respiratory problems like COPD.

Email Us For A Response

Free Consultation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Summers, Rufolo & Rodgers
735 Broad Street, Suite 800
Chattanooga, TN 37402-2913

Toll Free: 888-778-6575
Phone: 423-933-2738
Fax: 423-266-5211
Chattanooga Law Office Map

Review Us
735 Broad Street, Suite 800